HIA
PFE icon

HFM Investment Advisors’s Pfizer PFE Stock Holding History

HFM Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.2K Buy
1,146
+19
+2% +$506 0.01% 65
2025
Q4 		$28K Buy
1,127
+427
+61% +$10.8K 0.01% 71
2025
Q3 		$17.8K Buy
700
+12
+2% +$296 0.01% 69
2025
Q2 		$16.7K Buy
688
+55
+9% +$1.28K 0.01% 72
2025
Q1 		$16K Buy
+633
New +$16.6K 0.01% 66

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

HFM Investment Advisors's PFE Position: Q1 2026 in Review

HFM Investment Advisors increased its Pfizer (PFE) stake by 1.7% in Q1 2026, buying an estimated $506 and bringing the position to 1,146 shares worth $32.2K. The position accounts for 0.01% of the portfolio, ranked #65.

HFM Investment Advisors first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • HFM Investment Advisors held 1,146 shares of Pfizer worth $32.2K as of Q1 2026.
  • HFM Investment Advisors bought 19 Pfizer shares in Q1 2026, an estimated $506.
  • Pfizer made up 0.01% of HFM Investment Advisors's portfolio in Q1 2026, its #65 holding.
  • HFM Investment Advisors first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on HFM Investment Advisors's 13F filing for Q1 2026, filed 1 May 2026.